Status:
COMPLETED
LCI-GER-NOS-TAB-001: Tablet for Geriatric Assessment
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Self Geriatric Assessment Measure (SGAM)
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
The Self Geriatric Assessment Measure \[SGAM\] is based on a standard diagnostic tool used to evaluate geriatric cancer patients in order to determine the appropriateness of cancer directed therapy at...
Detailed Description
Primary Objective Assess and compare the proportions of subjects completing, defined as recording responses for at least 70% of actionable questions of the Self Geriatric Assessment Measure (SGAM) in...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Subjects must meet all of the following criteria:
- At least 70 years of age
- Histologically or cytologically confirmed malignancy within the past 1 year
- Ability to read and understand English
- Willingness to complete either tablet or paper based assessment independently and without assistance from caregiver, if applicable
- Willingness and ability to understand and sign a written informed consent document
- Exclusion Criteria
- Subjects must not meet any of the following criteria:
- Any prior history of whole brain radiation therapy for known brain metastasis
- Known cerebrovascular event within the last 4 weeks from enrollment
- Known to be legally blind or has a history of severe hearing loss that could impair ability to complete questionnaire in the opinion of the investigator
Exclusion
Key Trial Info
Start Date :
January 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2019
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT03419468
Start Date
January 12 2018
End Date
November 18 2019
Last Update
August 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Levine Cancer Institute
Charlotte, North Carolina, United States, 28203